Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Vicarious Surgical Inc. (RBOT)

2.205   0.105 (5%) 06-06 15:59
Open: 2.1 Pre. Close: 2.1
High: 2.315 Low: 2.08
Volume: 242,527 Market Cap: 280(M)

Technical analysis

as of: 2023-06-06 3:51:38 PM
Short-term rate:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Mid-term rate:       
Target: Six months: 2.86     One year: 3.34
Support: Support1: 2.09    Support2: 1.87
Resistance: Resistance1: 2.45    Resistance2: 2.86
Pivot: 2.14
Moving Average: MA(5): 2.16     MA(20): 2.11
MA(100): 2.43     MA(250): 3.02
MACD: MACD(12,26): 0     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 48.7     %D(3): 48.5
RSI: RSI(14): 52.5
52-week: High: 4.76  Low: 1.36
Average Vol(K): 3-Month: 351 (K)  10-Days: 204 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ RBOT ] has closed below upper band by 35.1%. Bollinger Bands are 39.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.25 - 2.27 2.27 - 2.28
Low: 2.07 - 2.09 2.09 - 2.1
Close: 2.08 - 2.1 2.1 - 2.12

Company Description

Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Headline News

Fri, 26 May 2023
Insider Sell: CFO and Treasure -

Thu, 18 May 2023
Vicarious Surgical Announces Promotion of John Mazzola to Chief ... - Business Wire

Mon, 08 May 2023
Vicarious Surgical Reports First Quarter 2023 Financial Results - Business Wire

Thu, 04 May 2023
Vicarious Surgical Earns Recognition from Fast Company and MedTech Breakthrough Awards - Yahoo Finance

Mon, 24 Apr 2023
Vicarious Surgical to Report First Quarter 2023 Financial Results on ... - Business Wire

Sat, 22 Apr 2023
While institutions invested in Vicarious Surgical Inc. (NYSE:RBOT) benefited from last week's 11% gain, private equity firms stood to gain the most - Simply Wall St

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 107 (M)
Shares Float 53 (M)
% Held by Insiders 35.7 (%)
% Held by Institutions 40.6 (%)
Shares Short 5,220 (K)
Shares Short P.Month 5,070 (K)

Stock Financials

EPS -0.56
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.68
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -35
Return on Equity (ttm) -59.6
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.78
Qtrly Earnings Growth 0
Operating Cash Flow -65 (M)
Levered Free Cash Flow -41 (M)

Stock Valuations

PE Ratio -4.02
PEG Ratio 0
Price to Book value 3.2
Price to Sales 0
Price to Cash Flow -3.65

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.